Search

Home > News & Events > Current News
20 March 2018 Focus on TB: Read about fight against TB in Cape Winelands
Mon, 19 Mar 2018 - 12:45

Read about news in the fight against TB. Lees nuus oor die stryd teen TB.

19 March 2018 Launch of TB under Spotlight Science Engagement
Mon, 19 Mar 2018 - 08:15

SATVI will be launching the "Tb Under the Spotlight Science Engagement" in partnership with the Department of Education, the SA MRC Centre for Tuberculosis Research, the DST/NRF Centre of Excellence for Biomedical Tuberculosis Research, Division of Molecular Biology and Human Genetics, Stellenbosch University  and UCT Anthropology on Tuesday 20 March 2018 in Worcester, Stellenbosch, and Robertson.

Vacancy Research Pharmacist
Tue, 21 Nov 2017 - 12:15

We have a vacancy for a Research Pharmacist at our Worcester Field site. NOW CLOSED

New Gobal commitment to end TB
Mon, 20 Nov 2017 - 08:30

On Friday 17 November 75 ministers announced a landmark agreement to take urgent action to end tuberculosis (TB) by 2030 at the conclusion of a World Health Organization (WHO) conference in Moscow, Russia, on eradicating the world's deadliest infectious disease.

Progression from infection to Pulmonary Tuberculosis follows distinct timeline
Fri, 17 Nov 2017 - 08:15

SATVI researchers have uncovered a sequence of biological processes that occur in humans infected with the bacterium Mycobacterium tuberculosis as the infection progresses to pulmonary tuberculosis, according to new research published in the PLOS Pathogens Journal

9 November 2017 Research Published: TBVAC2020: Advancing Tuberculosis Vaccines from Discovery to Clinical Development
Thu, 09 Nov 2017 - 14:15

Associate Professor Tom Scriba has collaborated with the authors of a research paper titled: "TBVAC2020: Advancing Tuberculosis Vaccines from Discovery to Clinical Development" appearing in the Frontiers in Immunology Journal.

25 October 2017 Research Published Polyfunctional CD4+TCells as targets for vaccination
Mon, 06 Nov 2017 - 14:45

Associate Professor Tom Scriba has co authored a research paper titled "Polyfunctional CD4+T Cells as targets for Tuberculosis Vaccination" appearing in the Frontiers in Immunology Journal.

5 October 2017 RESEARCH: Safety and Immunogenicity Immunogenicity of newborn MVA 85 A vaccination and selective delayed Bacille Calmette-Guerin for infants of HIV infected mothers: a Phase 2 Randomized Controlled Trial
Thu, 05 Oct 2017 - 11:30

SATVI authors Dr Elisa Nemes, Prof Mark Hatherill, Associate Prof Tom Scriba, Dr Michele Tameris, Humphrey Mulenga and Danelle Van As have published a research paper titled: "Safety and Immunogenicity of newborn MVA 85 A vaccination and selective delayed Bacille Calmette-Guerin for infants of HIV infected mothers: a Phase 2 randomized controlled trial" appearing in the Infectious Disease Journal (Oxford).

3 October 2017 Research: Host blood signatures RNA predict the outcome of tuberculosis treatment
Tue, 03 Oct 2017 - 10:30

Associate Professor Tom Scriba has co-authored a article titled: "Host blood RNA predict the outcome of tuberculosis treatment" appearing in the Tuberculosis Journal.

21 September 2017 Vacancy Research Officer: Systems Immunology
Thu, 21 Sep 2017 - 18:15

SATVI invites applications for the position of Research Officer: Systems Immunology at its Cape Town offices. CLOSED.

14 September 2017 Research: Application of a whole blood mycobacterial growth inhibition assay to study immunity against Mycobacterium tuberculosis in a high tuberculosis burden population
Fri, 15 Sep 2017 - 09:00

SATVI authors have published a research paper titled: "Application of a whole blood mycobacterial growth inhibition assay to study immunity against Mycobacterium tuberculosis in a high tuberculosis burden population" appearing in the PLoS ONE Journal.

8 September 2017 Research: A Functional Toll-Interacting Protein Variant associated with Bacillus Calmette-Guerin Specific Immune Response and Tuberculosis
Fri, 08 Sep 2017 - 08:00

Professor Mark Hatherill and Associate Professor Tom Scriba have co-authored a research paper titled "A Functional Toll-interacting Protein variant with Bacillus Calmette-Guerin specific immune responses and Tuberculosis" appearing in the American Journal of Respiratory and Critical Care Medicine.

Pages